Table 1 Patient characteristics
| Total | Adult | Children | Placebo | sc-LCPUFA | ||
|---|---|---|---|---|---|---|
| Subjects | [n] | 64 | 34 | 30 | 32 | 32 |
| Female/Male | [n] | 35/29 | 22/12 | 13/17 | 16/16 | 19/13 |
| Age | [yrs] | 19.0 ± 5.5 | 23.5 ± 3.0 | 13.8 ± 2.2 | 18.4 ± 5.0 | 19.5 ± 6.0 |
| Weight | [kg] | 61.0 ± 14.0 | 67.6 ± 12.4 | 53.6 ± 11.9 | 60.1 ± 13.6 | 62.0 ± 14.6 |
| Height | [m] | 1.7 ± 0.1 | 1.7 ± 0.1 | 1.6 ± 0.1 | 1.7 ± 0.1 | 1.7 ± 0.1 |
| FVC | [% pred] |
96.6 (70.2–140.1) |
94.0 (70.2–117.3) |
98.8 (77.7–140.1) |
96.7 (70.2–114.7) |
96.3 (82.6–140.1) |
| FEV1 | [% pred] |
94.9 (64.4–118.4) |
91.8 (64.4–115.2) |
97.3 (69.6–118.4) |
95.3 (64.4–111.0) |
92.9 (72.6–118.4) |
| eNO | [ppb] |
27.5 (5.0–197.0) |
27.5 (5.0–197.0) |
28.5 (7.0–88.0) |
31.5 (6.0–96.0) |
20.5 (5.0–197.0) |
| ACQ |
0.7 (0.0–2.9) |
0.7 (0.0–2.9) |
0.8 (0.0–2.0) |
0.9 (0.0–2.9) |
0.7 (0.0–2.0) | |